Allarity Therapeutics, Inc.(ALLR)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

Allarity Therapeutics, Inc. (ALLR) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores ALLR at 10.2/100 on a 32-signal composite quality model, placing it at rank #2,911 of 2,961 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (Q2 2026), Allarity Therapeutics, Inc. reports net income of $-3.4M, free cash flow of $-2.6M. Top institutional holders of ALLR by reported 13-F value include RENAISSANCE TECHNOLOGIES, VANGUARD CAPITAL MANAGEMENT, GEODE CAPITAL MANAGEMENT, based on the most recent SEC filings. ALLR trades on the Nasdaq exchange and files with the SEC under CIK 1860657. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ALLR daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Allarity Therapeutics, Inc. directly from SEC EDGAR.